Cetera Investment Advisers
NVO

Cetera Investment Advisers’s Novo Nordisk NVO Stock Holding History

Cetera Investment Advisers’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-200
Closed -$168 – 4912
2025
Q4 		$168 Buy
+200
New +$10.2K ﹤0.01% 4668

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Cetera Investment Advisers's NVO Position: Q1 2026 in Review

Cetera Investment Advisers increased its Novo Nordisk (NVO) stake by 38% in Q1 2026, buying an estimated $5.22M and bringing the position to 396,557 shares worth $14.6M. The position accounts for 0.02% of the portfolio, ranked #845.

Cetera Investment Advisers first reported a position in NVO in Q3 2018 and has held it in 31 quarters since. The position peaked at $41.5M in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Cetera Investment Advisers held 396,557 shares of Novo Nordisk worth $14.6M as of Q1 2026.
  • Cetera Investment Advisers bought 110,186 Novo Nordisk shares in Q1 2026, an estimated $5.22M.
  • Novo Nordisk made up 0.02% of Cetera Investment Advisers's portfolio in Q1 2026, its #845 holding.
  • Cetera Investment Advisers first reported a position in Novo Nordisk in Q3 2018 and has held it in 31 quarters since.
  • Cetera Investment Advisers's Novo Nordisk position peaked at $41.5M in Q2 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.